Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. [electronic resource] by
- Lala, Mallika
- Li, Tommy Ruosi
- de Alwis, Dinesh P
- Sinha, Vikram
- Mayawala, Kapil
- Yamamoto, Noboru
- Siu, Lillian L
- Chartash, Elliot
- Aboshady, Hesham
- Jain, Lokesh
Producer: 20201027
In:
European journal of cancer (Oxford, England : 1990) vol. 131
Availability: No items available.
|
|
|
15.
|
Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models. [electronic resource] by
- Bruno, René
- Bottino, Dean
- de Alwis, Dinesh P
- Fojo, Antonio T
- Guedj, Jérémie
- Liu, Chao
- Swanson, Kristin R
- Zheng, Jenny
- Zheng, Yanan
- Jin, Jin Y
Producer: 20210127
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
16.
|
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours. [electronic resource] by
- Lê, Lyly H
- Moore, Malcolm J
- Siu, Lillian L
- Oza, Amit M
- MacLean, Martha
- Fisher, Bryn
- Chaudhary, Ajai
- de Alwis, Dinesh P
- Slapak, Christopher
- Seymour, Lesley
Producer: 20050802
In:
Cancer chemotherapy and pharmacology vol. 56
Availability: No items available.
|
|
|
17.
|
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma. [electronic resource] by
- Ryan, Christopher W
- Matias, Chacon
- Agulnik, Mark
- Lopez-Pousa, Antonio
- Williams, Charles
- de Alwis, Dinesh P
- Kaiser, Christopher
- Miller, Mary Alice
- Ermisch, Sabine
- Ilaria, Robert
- Keohan, M L
Producer: 20130731
In:
Investigational new drugs vol. 31
Availability: No items available.
|
|
|
18.
|
A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. [electronic resource] by
- Baetz, Tara
- Eisenhauer, Elizabeth
- Siu, Lillian
- MacLean, Martha
- Doppler, Karen
- Walsh, Wendy
- Fisher, Bryn
- Khan, Azhar Z
- de Alwis, Dinesh P
- Weitzman, A
- Brail, Leslie H
- Moore, Malcolm
Producer: 20070730
In:
Investigational new drugs vol. 25
Availability: No items available.
|
|
|
19.
|
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma. [electronic resource] by
- Kirkwood, John M
- Gonzalez, Rene
- Reintgen, Douglas
- Clingan, Philip R
- McWilliams, Robert R
- de Alwis, Dinesh P
- Zimmermann, Annamaria
- Brown, Michael P
- Ilaria, Robert L
- Millward, Michael J
Producer: 20121207
In:
Cancer vol. 117
Availability: No items available.
|
|
|
20.
|
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy. [electronic resource] by
- Sandler, Alan
- Gordon, Michael
- De Alwis, Dinesh P
- Pouliquen, Isabelle
- Green, Lisa
- Marder, Phil
- Chaudhary, Ajai
- Fife, Karen
- Battiato, Linda
- Sweeney, Christopher
- Jordan, Christopher
- Burgess, Michael
- Slapak, Christopher A
Producer: 20041210
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10
Availability: No items available.
|